"Welcome to UT Physicians Women’s Centers, where you will receive a quality, compassionate and supportive health care experience. Schedule an appointment at one of our convenient locations across Southeast Texas."

During the past decade, UT Health Women's Research Center at Memorial City conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "UT Health Women's Research Center at Memorial City" are "Hot Flashes" (2 trials), "Vasomotor Symptoms Associated With Menopause" (2 trials), "Endometriosis" (1 trials) and "Respiratory Tract Infection" (1 trials). Many other conditions were trialed in "UT Health Women's Research Center at Memorial City" in a lesser frequency.

Most popular intervention types in "UT Health Women's Research Center at Memorial City" are "Drug" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Elinzanetant (BAY3427080)" (2 trials), "BAY1817080" (1 trials), "Elagolix" (1 trials) and "RSVpreF" (1 trials). Other intervention names were less common.

The vast majority of trials in "UT Health Women's Research Center at Memorial City" are 4 trials for "Female" genders.

Currently, there are NaN active trials in "UT Health Women's Research Center at Memorial City". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in UT Health Women's Research Center at Memorial City, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UT Health Women's Research Center at Memorial City, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".